<VariationArchive VariationID="953991" VariationName="NM_000017.4(ACADS):c.492_513del (p.Ala165fs)" VariationType="Deletion" Accession="VCV000953991" Version="7" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-02-20" DateCreated="2020-07-16" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="947798" VariationID="953991">
      <GeneList>
        <Gene Symbol="ACADS" FullName="acyl-CoA dehydrogenase short chain" GeneID="35" HGNC_ID="HGNC:90" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.31</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="120725826" stop="120740008" display_start="120725826" display_stop="120740008" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="121163570" stop="121177810" display_start="121163570" display_stop="121177810" Strand="+" />
          </Location>
          <OMIM>606885</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000017.4(ACADS):c.492_513del (p.Ala165fs)</Name>
      <CanonicalSPDI>NC_000012.12:120737853:GGAGCTGCGTCCACCACCGCCCGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.31</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="120737854" stop="120737875" display_start="120737854" display_stop="120737875" variantLength="22" positionVCF="120737853" referenceAlleleVCF="AGGAGCTGCGTCCACCACCGCCC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="121175657" stop="121175678" display_start="121175657" display_stop="121175678" variantLength="22" positionVCF="121175656" referenceAlleleVCF="AGGAGCTGCGTCCACCACCGCCC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>A165fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.121175659_121175680del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.121175659_121175680del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.120737856_120737877del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.120737856_120737877del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007991.1" sequenceAccession="NG_007991" sequenceVersion="1" change="g.17089_17110del">
            <Expression>NG_007991.1:g.17089_17110del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000017.4" sequenceAccession="NM_000017" sequenceVersion="4" change="c.492_513del" MANESelect="true">
            <Expression>NM_000017.4:c.492_513del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000008.1" sequenceAccession="NP_000008" sequenceVersion="1" change="p.Ala165fs">
            <Expression>NP_000008.1:p.Ala165fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001302554.2" sequenceAccession="NM_001302554" sequenceVersion="2" change="c.473-193_473-172del">
            <Expression>NM_001302554.2:c.473-193_473-172del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="745833347" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000017.4(ACADS):c.492_513del (p.Ala165fs) AND Deficiency of butyryl-CoA dehydrogenase" Accession="RCV001226367" Version="4">
        <ClassifiedConditionList TraitSetID="1053">
          <ClassifiedCondition DB="MedGen" ID="C0342783">Deficiency of butyryl-CoA dehydrogenase</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-07-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000017.4(ACADS):c.492_513del (p.Ala165fs) AND not provided" Accession="RCV002298909" Version="2">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-07-28" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2020-07-16" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12736383</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18523805</ID>
        </Citation>
        <DescriptionHistory Dated="2022-05-15">
          <Description>Uncertain significance</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1053" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="82" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lipid-storage myopathy secondary to short chain acyl CoA dehydrogenase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">SCAD DEFICIENCY, MILD</ElementValue>
                <XRef Type="Allelic variant" ID="606885.0015" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606885.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606885.0014" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ACYL-CoA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF</ElementValue>
                <XRef Type="MIM" ID="201470" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Deficiency of butyryl-CoA dehydrogenase</ElementValue>
                <XRef ID="Short+chain+acyl+CoA+dehydrogenase+deficiency/6545" DB="Genetic Alliance" />
                <XRef ID="124166007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">SCAD</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">ACADSD</ElementValue>
                <XRef Type="MIM" ID="201470" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4822" />
                <XRef ID="4822" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism">May be benign</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Most infants with short-chain acyl-CoA dehydrogenase deficiency (SCADD) identified through newborn screening programs have remained well, and asymptomatic relatives who meet diagnostic criteria are reported. Thus, SCADD is now viewed as a biochemical phenotype rather than a disease. A broad range of clinical findings was originally reported in those with confirmed SCADD, including severe dysmorphic facial features, feeding difficulties / failure to thrive, metabolic acidosis, ketotic hypoglycemia, lethargy, developmental delay, seizures, hypotonia, dystonia, and myopathy. However, individuals with no symptoms were also reported. In a large series of affected individuals detected on metabolic evaluation for developmental delay, 20% had failure to thrive, feeding difficulties, and hypotonia; 22% had seizures; and 30% had hypotonia without seizures. In contrast, the majority of infants with SCADD have been detected by expanded newborn screening, and the great majority of these infants remain asymptomatic. As with other fatty acid oxidation deficiencies, characteristic biochemical findings of SCADD may be absent except during times of physiologic stress such as fasting and illness. A diagnosis of SCADD based on clinical findings should not preclude additional testing to look for other causes.</Attribute>
                <XRef ID="NBK63582" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">21938826</ID>
                <ID Source="BookShelf">NBK63582</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C4.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C4 Acylcarnitine, Short-Chain Acyl-CoA Dehydrogenase (SCAD) Deficiency, 2022</CitationText>
              </Citation>
              <XRef ID="26792" DB="Orphanet" />
              <XRef ID="C0342783" DB="MedGen" />
              <XRef ID="MONDO:0008722" DB="MONDO" />
              <XRef Type="MIM" ID="201470" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5057406" SubmissionDate="2022-10-31" DateLastUpdated="2023-03-04" DateCreated="2022-11-05">
        <ClinVarSubmissionID localKey="GDXSV:245794" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002588123" DateUpdated="2023-03-04" DateCreated="2022-11-05" Type="SCV" Version="2" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADS" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1822175</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000017.2:c.492_513del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_137_20221031152118</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2733648" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="4711821|MedGen:C0342783" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001398679" DateUpdated="2024-02-14" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-07-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12736383</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18523805</ID>
          </Citation>
          <Comment>ClinVar contains an entry for this variant (Variation ID: 953991). This variant has not been reported in the literature in individuals affected with ACADS-related conditions. This variant is present in population databases (rs745833347, gnomAD 0.008%). This sequence change creates a premature translational stop signal (p.Ala165Profs*8) in the ACADS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ACADS are known to be pathogenic (PMID: 12736383, 18523805). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ACADS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.121175657_121175678del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0342783" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5057406" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2733648" TraitType="Disease" MappingType="XRef" MappingValue="C0342783" MappingRef="MedGen">
        <MedGen CUI="C0342783" Name="Deficiency of butyryl-CoA dehydrogenase" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

